• In the past week, Colgate-Palmolive reported first-quarter 2026 results showing net sales rising to US$5,324 million from US$4,911 million a year earlier, while GAAP diluted earnings per share from continuing operations eased to US$0.80 from US$0.85.
• The company also reaffirmed its full-year 2026 sales outlook and expanded its multi-year Strategic Growth and Productivity Program, aiming for US$200 million to US$300 million in annualized savings mainly from 2027 and 2028 to help offset higher raw material and logistics costs.
• Next, we’ll assess how the solid sales growth and expanded productivity program affect Colgate-Palmolive’s pre-existing investment narrative and long-term assumptions.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Colgate-Palmolive Investment Narrative Recap

To own Colgate-Palmolive, you need to believe in its global brands, everyday-use categories and long-term growth in emerging markets, supported by consistent reinvestment in innovation and marketing. The latest quarter reinforced that sales momentum can coexist with near term margin pressure, so the key short term catalyst remains management’s ability to offset higher raw material and logistics costs, while the biggest risk is that these cost headwinds persist and limit earnings progress.

The expansion of Colgate-Palmolive’s multi-year Strategic Growth and Productivity Program, targeting US$200 million to US$300 million in annualized savings mainly in 2027 and 2028, is most relevant here. It directly addresses inflationary cost pressure and supports the existing narrative that productivity initiatives can help protect margins and fund future brand and digital investments, even as categories in some markets stay soft.

Yet investors should be aware that cost inflation and a lower gross margin outlook could still weigh on results if...

Colgate-Palmolive's narrative projects $22.8 billion revenue and $3.5 billion earnings by 2029. This requires 3.8% yearly revenue growth and a $1.4 billion earnings increase from $2.1 billion today.

Uncover how Colgate-Palmolive's forecasts yield a $96.68 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Five members of the Simply Wall St Community currently estimate Colgate-Palmolive’s fair value between US$78.22 and US$120.72, highlighting very different expectations about future returns. You can weigh those views against the recent cost inflation risk and expanded productivity program to see how different assumptions about margins and growth shape the company’s potential performance.

Explore 5 other fair value estimates on Colgate-Palmolive - why the stock might be worth 10% less than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Colgate-Palmolive research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Colgate-Palmolive research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Colgate-Palmolive's overall financial health at a glance.

Want Some Alternatives?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.